HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy

Science
John T HinsonC E Seidman

Abstract

Human mutations that truncate the massive sarcomere protein titin [TTN-truncating variants (TTNtvs)] are the most common genetic cause for dilated cardiomyopathy (DCM), a major cause of heart failure and premature death. Here we show that cardiac microtissues engineered from human induced pluripotent stem (iPS) cells are a powerful system for evaluating the pathogenicity of titin gene variants. We found that certain missense mutations, like TTNtvs, diminish contractile performance and are pathogenic. By combining functional analyses with RNA sequencing, we explain why truncations in the A-band domain of TTN cause DCM, whereas truncations in the I band are better tolerated. Finally, we demonstrate that mutant titin protein in iPS cell-derived cardiomyocytes results in sarcomere insufficiency, impaired responses to mechanical and β-adrenergic stress, and attenuated growth factor and cell signaling activation. Our findings indicate that titin mutations cause DCM by disrupting critical linkages between sarcomerogenesis and adaptive remodeling.

References

Sep 11, 2002·Circulation·Ciprian NeagoeWolfgang A Linke
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·John L TanChristopher S Chen
Jan 3, 2006·Nature Biotechnology·Tenneille E LudwigJames A Thomson
Jan 10, 2008·Nature Biotechnology·Stephen A Sherwin
Feb 4, 2009·Molecular and Cellular Biology·Sadakatsu IkedaWilliam T Pu
Jun 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Wesley R LegantChristopher S Chen
Dec 19, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lorena ZentilinMauro Giacca
Jul 14, 2010·Cell Stem Cell·Yuin-Han LohGeorge Q Daley
Oct 11, 2011·Nature Biotechnology·Florian LeuschnerMatthias Nahrendorf
Nov 19, 2011·Tissue Engineering. Part a·Thomas BoudouChristopher S Chen
Feb 4, 2012·Cold Spring Harbor Protocols·Andrea L Szymczak-WorkmanDario A A Vignali
Feb 18, 2012·The New England Journal of Medicine·Daniel S HermanChristine E Seidman
Oct 20, 2012·Nature Reviews. Drug Discovery·Eva van Rooij, Eric N Olson
Dec 19, 2012·Cell Stem Cell·Qiurong DingChad A Cowan
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Aug 1, 2013·Nature Reviews. Cardiology·Ray E HershbergerAna Morales
Nov 5, 2013·Nature Methods·Pär G EngströmUNKNOWN RGASP Consortium
Nov 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nimalan ThavandiranPeter W Zandstra
Feb 11, 2014·The Journal of Clinical Investigation·Danos C ChristodoulouJ G Seidman
Apr 15, 2014·Nature Methods·Kai WangEric Betzig
Jan 13, 2015·Nature Biotechnology·Christina Fournier, Jonathan D Glass
May 13, 2015·Nature Biotechnology·Cormac Sheridan
May 13, 2015·Nature Biotechnology·Anastasia KhvorovaMatthew R Hassler

❮ Previous
Next ❯

Citations

Oct 3, 2015·Advanced Drug Delivery Reviews·Anurag MathurKevin E Healy
Jan 15, 2016·Nature Reviews. Cardiology·Donna K Arnett
Mar 5, 2016·Cell Stem Cell·Robert PassierChristine Mummery
Nov 19, 2015·Biochimica Et Biophysica Acta·Elisabeth Ehler
Mar 25, 2016·Nature Reviews. Cardiology·Ian Y ChenJoseph C Wu
Apr 16, 2016·Scientific Reports·Yong LiWolfgang A Linke
Mar 30, 2016·Current Opinion in Cardiology·Anita M ChananaJoseph C Wu
Apr 29, 2016·Nature Methods·William J Polacheck, Christopher S Chen
Apr 27, 2016·Cell·Jennifer DavisJeffery D Molkentin
May 7, 2016·Journal of the American College of Cardiology·Nazish SayedJoseph C Wu
May 12, 2016·Biomedical Microdevices·Benoît KalmanThomas Boudou
Jun 15, 2016·Trends in Cardiovascular Medicine·Samantha Barratt RossChristopher Semsarian
Jun 20, 2016·Biomaterials·Hemanth GudapatiIbrahim Ozbolat
Aug 19, 2016·Frontiers in Physiology·Matthew J Brody, Youngsook Lee
Aug 6, 2016·Human Molecular Genetics·Stormy J Chamberlain
Nov 5, 2016·Nature Reviews. Cardiology·Alanna Strong, Kiran Musunuru
Oct 21, 2016·Expert Opinion on Drug Safety·Yimu ZhaoMilica Radisic
Oct 25, 2016·Trends in Cell Biology·Christopher S Chen
May 14, 2016·Journal of Cellular Physiology·Marie-Louise Bang
Oct 25, 2016·International Journal of Cardiology·Alexandra Pérez-SerraOscar Campuzano
Oct 22, 2016·Seminars in Cell & Developmental Biology·Krzysztof JaglaSabrina Batonnet-Pichon
Nov 5, 2016·European Journal of Heart Failure·Joeri A JansweijerYigal M Pinto
Dec 17, 2016·Cell·Ana VujicRichard T Lee
Aug 31, 2016·Scientific Reports·Jonas SchwanStuart G Campbell
Mar 30, 2017·Canadian Journal of Physiology and Pharmacology·Adrien MoreauMohamed Chahine
Feb 6, 2017·Current Opinion in Cardiology·Diane Fatkin, Inken G Huttner
Jul 21, 2017·Integrative Biology : Quantitative Biosciences From Nano to Macro·Nethika R AriyasingheMegan L McCain
Mar 17, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Despina D BrianaAriadne Malamitsi-Puchner
Dec 15, 2017·Nature Reviews. Cardiology·James S Ware, Stuart A Cook
Mar 29, 2018·PloS One·Francesco Silvio PasqualiniKevin Kit Parker
Jan 25, 2018·Current Protocols in Human Genetics·Arun SharmaChristine E Seidman
Jan 29, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Glenn C RoweZoltan Arany
Nov 12, 2016·Development·Yu-Huan ShihXiaolei Xu
Dec 20, 2017·Cancer Cell International·Nicolette M ClarkGeorge Blanck
Dec 22, 2017·NPJ Genomic Medicine·Lamis YehiaCharis Eng
Apr 4, 2017·Clinical Genetics·M Sabater-MolinaJ R Gimeno
Jul 25, 2017·BioResearch Open Access·Takaharu NegoroAkifumi Matsuyama
Jun 16, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Nethika R AriyasingheMegan L McCain

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.